Molecular Human Reproduction Vol. 2, NUMBER 4 pp. 259-264, 1996
© European Society of Human Reproduction and Embryology 1996
research-article |
Endocrinology and Paracrinology
Gonadotrophin-releasing hormone and triptorelin inhibit the follicle stimulating hormone-induced response in human primary cultured granulosa-lutein cells
1INSERM U 361 123 Boulevard de Port-Royal, 75014 Paris, France 2Clinique Universitaire Baudelocque, Maternité Baudelocque 123 Boulevard de Port-Royal, 75014 Paris, France
To whom correspondence should be addressed at: 3To whom correspondence should be addressed
Cyclic AMP (c-AMP)-dependent cell shape changes can be used to study the gonadotrophin response in cultured human granulosa-lutein cells. The same approach has been developed here to determine the direct potential antigonadotrophic effect of gonadotrophin-releasing hormone (GnRH) and a GnRH agonist (triptorelin) on human granulosa-lutein cells. Treatment with triptorelin or GnRH alone for 1 h did not affect granulosa-lutein cell morphology. However, in the presence of stimulatory doses of follicle stimulating hormone (FSH), triptorelin 5x1075x106 M) and GnRH (1011109 M) inhibited the FSH-induced c-AMP-dependent response. The antigonadotrophic effect of triptorelin was prevented by two GnRH antagonists, indicating that triptorelin acts via specific GnRH binding sites. On the other hand, triptorelin failed to inhibit human chorionic gonadotrophin- and forskolin-mediated morphological changes. Our results suggest that the GnRH agonist interacts specifically with the FSH-induced c-AMP-dependent cascade of events, at a site located ahead of that of c-AMP generation. In conclusion, GnRH and triptorelin strongly inhibit FSH-mediated function in human granulosa-lutein cells in culture. This inhibition might play a role in the low follicular development rates observed in some patients treated with GnRH agonist + gonadotrophins for ovarian stimulation.
cell shape changes/FSH/GnRH/human granulosa-lutein cells/triptorelin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Kitajima, T. Endo, K. Nagasawa, K. Manase, H. Honnma, T. Baba, T. Hayashi, H. Chiba, N. Sawada, and T. Saito Hyperstimulation and a Gonadotropin-Releasing Hormone Agonist Modulate Ovarian Vascular Permeability by Altering Expression of the Tight Junction Protein Claudin-5 Endocrinology, February 1, 2006; 147(2): 694 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Yeung, B.-S. An, C. K. Cheng, B. K.C. Chow, and P. C.K. Leung Expression and transcriptional regulation of the GnRH receptor gene in human neuronal cells Mol. Hum. Reprod., November 1, 2005; 11(11): 837 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng, C. M. Yeung, B. K. C. Chow, and P. C. K. Leung Characterization of a New Upstream GnRH Receptor Promoter in Human Ovarian Granulosa-Luteal Cells Mol. Endocrinol., July 1, 2002; 16(7): 1552 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ortmann, J.M. Weiss, and K. Diedrich Embryo implantation and GnRH antagonists: Ovarian actions of GnRH antagonists Hum. Reprod., April 1, 2001; 16(4): 608 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dor, D. Bider, A. Shulman, J. Levron, S. Shine, S. Mashiach, and J. Rabinovici Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro--results of a prospective, randomized in-vitro fertilization study Hum. Reprod., June 1, 2000; 15(6): 1225 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Nathwani, S. K. Kang, K. W. Cheng, K.-C. Choi, and P. C. K. Leung Regulation of Gonadotropin-Releasing Hormone and Its Receptor Gene Expression by 17{beta}-Estradiol in Cultured Human Granulosa-Luteal Cells Endocrinology, May 1, 2000; 141(5): 1754 - 1763. [Abstract] [Full Text] [PDF] |
||||



